Pre-Eclampsia Clinical Trials
2 recruiting trials for Pre-Eclampsia. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Pre-Eclampsia clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Ankara Etlik City Hospital (1), Imperial College Healthcare NHS Trust (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is FHC dimensions in EOPE and control groups (other, 1 trial), followed by Vicorder: pulse wave velocity, pulse wave analysis, stroke volume, cardiac output, NICaS.
Track Pre-Eclampsia trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Fetal Fornix and Hippocampus in Pregnant Women With Early-Onset Preeclampsia
Since early-onset preeclampsia (EOPE) is commonly associated with inadequate placentation, placental insufficiency, chronic fetal hypoxia, oxidative stress, and heightened...
Bioimpedence and Arterial Function Monitoring at Birth and in Infants
Babies may be born appropriately grown for gestational age (AGA, \>10th centile) or small for gestational age (SGA, \<10th centile). Babies who are SGA and have evidence in utero...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Pre-Eclampsia, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Pre-Eclampsia, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Pre-Eclampsia, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.